Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0597f9c318d2aeca86db94711c516383 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-70 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2875 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-468 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-241 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2019-05-08^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bafce4c64dd96a8e5c0406e5055c1ef4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d7474dc1e89ac2010f8579e4e68e485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f96bd53f041bd86e4914088dacb8a3f1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71e604bdacf59ec5ed6d07f2326296bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e63f80e210370a78bb7c6e58782b4590 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0abf114f105bc33bc73453630cd4ccca http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae3750eba4756adcd43e8372047d7dbb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a29a858bd1234b41f5dd2dade03a8c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a8a83a8a21429ca7777f9ed47fd677a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55985e2afcc21e3665fbfa47afa9ab7b |
publicationDate |
2021-03-17^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-3790904-A1 |
titleOfInvention |
Bispecific antibodies with cleavable c-terminal charge-paired tags |
abstract |
The present invention is directed to a CH3-containing molecule comprising (a) a first polypeptide comprising a CH3 domain and a negatively charged domain comprising consecutive negatively charged amino acid residues; and (b) a second polypeptide comprising a CH3 domain and a positively charged domain comprising consecutive positively charged amino acid residues. Also provided are methods for conjugating synthetic molecules to a multi-specific antigen binding molecule. |
priorityDate |
2018-05-08^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |